Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Rev Neurol

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    December 2022
  1. LOPEZ-ANGUITA S, Gutierrez-Ruano B, Munoz-Gonzalez A, Valenzuela-Rojas FJ, et al
    [Epilepsy in cancer patients: primary prevention and the importance of high-risk patient screening].
    Rev Neurol. 2022;75:349-356.
    PubMed     Abstract available

    November 2022
  2. JUIZ-FERNANDEZ A, Chavarria-Miranda A, Prieto-Gonzalez A, Rodriguez-Osorio X, et al
    [No fear of anything: epilepsy, psychiatric comorbidity and surgery. A clinical case report].
    Rev Neurol. 2022;75:319-321.
    PubMed     Abstract available

  3. SERRANO-TABARES C, Trujillo-Gomez J, Morales-Gil RM, Aguilar-Perez Y, et al
    Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.
    Rev Neurol. 2022;75:305-310.
    PubMed     Abstract available

  4. NAVA-CEDENO DJ, Alonso-Cerezo MC, Sanz-Garcia A, Vega-Zelaya L, et al
    [Association between single nucleotide genetic polymorphisms in ABC transporter genes with drug-resistant epilepsy in the Spanish population].
    Rev Neurol. 2022;75:251-259.
    PubMed     Abstract available

    October 2022
  5. SOTO-INSUGA V, Gonzalez-Alguacil E, Garcia-Penas JJ
    [Paediatric status epilepticus].
    Rev Neurol. 2022;75:225-238.
    PubMed     Abstract available

    September 2022
  6. RUBIO-NAZABAL E, Alvarez-Perez P, Cores-Bartolome C, Lema-Facal T, et al
    [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
    Rev Neurol. 2022;75:159-163.
    PubMed     Abstract available

    July 2022
  7. SANCHEZ-ZAPATA P, Zapata-Berruecos JF, Pelaez-Sanchez RG
    [Structural changes to the brain in drug-resistant juvenile myoclonic epilepsy].
    Rev Neurol. 2022;75:23-30.
    PubMed     Abstract available

  8. ARTEAGA-RODRIGUEZ C, Menine-Kubis M, Teixeira-Arteaga CB, Hernandez-Fustes OJ, et al
    Clinical characteristics of patients with epilepsy attending primary health care.
    Rev Neurol. 2022;75:7-12.
    PubMed     Abstract available

    June 2022
  9. ANAYA-GONZALEZ JL, Lopez-Munoz F, Carmona-Alvarez Builla E, Miniet-Castillo AE, et al
    [Correlation between clinical and tomographic variables in patients with neurocysticercosis. A study in a cohort of patients in Sierra Norte, Ecuador, between 2019 and 2020].
    Rev Neurol. 2022;74:383-391.
    PubMed     Abstract available

    May 2022
  10. MOSCOL G, Espino PH, Mayor LC, Burneo JG, et al
    [Epilepsy with catamenial pattern].
    Rev Neurol. 2022;74:303-311.
    PubMed     Abstract available

    April 2022
  11. CATALAN-AGUILAR J, Lozano-Garcia A, Gonzalez-Bono E, Villanueva V, et al
    Academic and employment insertion as a factor related to quality of life in patients with drug-resistant temporal lobe epilepsy.
    Rev Neurol. 2022;74:219-227.
    PubMed     Abstract available

    March 2022
  12. NOGUEIRA M, Melo C, Grangeia A, Magalhaes T, et al
    PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Rev Neurol. 2022;74:170-173.
    PubMed     Abstract available

    December 2021
  13. TOLEDANO R, Gil-Nagel A
    [Treatment of epilepsy with perampanel: conversion from add-on therapy to monotherapy].
    Rev Neurol. 2021;73.
    PubMed     Abstract available

  14. SANABRIA-SANCHINEL AA, Escobar-Pineda ES, Oliveros I, Perdomo-Mendizabal AL, et al
    [Telemedicine and epilepsy: healthcare experience of a national reference center during the COVID-19 pandemic].
    Rev Neurol. 2021;73:390-393.
    PubMed     Abstract available

    October 2021
  15. CANO-LOPEZ I, Vazquez-Costa JF, Gutierrez A, Villanueva V, et al
    [Cognitive reserve as a modulating factor in the impact of surgery on visual memory and naming in temporal lobe epilepsy patients].
    Rev Neurol. 2021;73:267-274.
    PubMed     Abstract available

  16. FERNANDEZ-ALONSO C, Gonzalez-Martinez F, Alonso-Aviles R, Linan-Lopez M, et al
    [On the treatment of epileptic seizures in patients with epilepsy in hospital emergency departments].
    Rev Neurol. 2021;73:258-259.

  17. NAVARRO-PEREZ MP, Viloria-Alebesque A

    Rev Neurol. 2021;73:259-260.

    September 2021
  18. GARCIA-PENAS JJ, Gil Nagel-Rein A, Sanchez-Carpintero R, Villanueva-Haba V, et al
    Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    Rev Neurol. 2021;73.
    PubMed     Abstract available

  19. CANTARIN-EXTREMERA V, Bernardino-Cuesta B, Martin-Villaescusa C, Melero-Llorente J, et al
    [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
    Rev Neurol. 2021;73:141-150.
    PubMed     Abstract available

    July 2021
  20. MARTINEZ-PIAS E, Castineira-Mourenza JA, Prieto-Gonzalez AJ, Rodriguez-Osorio X, et al
    [Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
    Rev Neurol. 2021;73:77-79.
    PubMed     Abstract available

  21. CARDENAL-MUNOZ E, Nabbout R, Boronat S, Lara-Herguedas J, et al
    Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown.
    Rev Neurol. 2021;73:57-65.
    PubMed     Abstract available

    June 2021
  22. NAVARRO-PEREZ MP, Viloria-Alebesque A, Garces-Anton E, Marin-Gracia M, et al
    [Emergency department management of epileptic seizures in patients with epilepsy].
    Rev Neurol. 2021;72:419-425.
    PubMed     Abstract available

    April 2021
  23. VILLANUEVA V, Carreno-Martinez M, Gil Nagel-Rein A, Lopez-Gonzalez FJ, et al
    New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Rev Neurol. 2021;72.
    PubMed     Abstract available

  24. HERNANDEZ-RUBIO L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Saez A, et al
    [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
    Rev Neurol. 2021;72:263-268.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.